HOME >> BIOLOGY >> NEWS
UF researchers score gene therapy advance: Animal study shows high blood pressure prevented in future generations

GAINESVILLE---A form of gene therapy to ward off high blood pressure in rats appears to permanently alter the animals' DNA blueprint, preventing their offspring from inheriting the disorder, University of Florida scientists report today (11/12) in Circulation Research: Journal of the American Heart Association.

The advance represents the first time researchers have been able to protect future generations through gene therapy for any condition, said UF molecular physiologist Mohan K. Raizada. Other studies have shown random bits of inserted genes can be passed on, but with no therapeutic effect. The new approach involves using a form of genetic brilliance to block the action of a harmful hormone, angiotensin, which causes blood vessels to narrow, increasing blood pressure.

"The neat part of this study is we're able to show both the effects on high blood pressure as well as on the organs involved in the control of blood pressure," Raizada said. "We have shown that this form of gene therapy not only prevents these animals from developing high blood pressure but also prevents a lot of other types of pathophysiological changes in the heart, the kidney and the arteries."

What's more, after studying two subsequent generations of rats - the original animals' "children" and "grandchildren" - researchers discovered the beneficial changes were passed on. Those offspring should have had high blood pressure but didn't, said UF vascular biologist

Craig H. Gelband. Raizada and Gelband, who are affiliated with UF's College of Medicine and the campuswide Genetics Institute, collaborated with Michael J. Katovich, in the university's College of Pharmacy on the study. The project was funded by the National Institutes of Health and the

American Heart Association's Florida affiliate. Findings from related research also were presented at this week's annual meeting of the American Heart Association in Atlanta.

While it may be years before the approach is teste
'"/>

Contact: Melanie Fridl Ross
ufcardiac@aol.com
352-690-7051
University of Florida
10-Nov-1999


Page: 1 2 3

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... KICVentures announced today its plans ... Orthopedic and Pain Management-Driven ASC Conference in Chicago on Thursday, June 13th at 6:30 ... Dr. Chicago, IL in the 3rd floor Ticino Hospitality room in space #74T. , ...
(Date:6/11/2019)... ... 10, 2019 , ... Improved Pharma LLC announces the publication of “Predictive and ... The article was published online on April 29th, 2019. The authors are Stephen ... Chen of Purdue University. , The article is the most recent addition to a ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a ... advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. ... that provides services to more than one dozen hospitals and surgery centers in ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
(Date:6/11/2019)... CITY, Calif. (PRWEB) , ... June 10, 2019 ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to DeepDyve’s ... of physics-related content to DeepDyve’s continually expanding library of more than 20 million ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
(Date:5/22/2019)... ... 22, 2019 , ... Artemis (formerly Agrilyst), the leading enterprise Cultivation ... round co-led by Astanor Ventures and Talis Capital with participation ... iSelect Fund . The company has raised $11.75m to date and will use the ...
Breaking Biology Technology:
Cached News: